Serial 99187857
Live / Applied — Extension of time to oppose received (as of 10 Mar 2026)
What this means for you
Not registered yet, but its 15 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99187857
- Mark type
- Design / logo
- Filed
- 15 May 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Danny Awdeh
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly; all for human use
Owner
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
- Crinetics Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 10 Mar 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Nov 2025 — NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 25 Nov 2025 — NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 25 Nov 2025 — REPORT UNRESPONSIVE AMENDMENT - COMPLETED
- 13 Nov 2025 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 13 Nov 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 29 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Sept 2025 — NON-FINAL ACTION E-MAILED